PTH and Hypercalcemia: In our subject, instead, there is evidence of hypercalciuria, in line with Carling et al. study [19], that identified a family with a heterozygous inactivating mutation of the cytoplasmic domain of the CaSR, not far from that of the patients in our study, associated with hypercalcemia, hypercalciuria and unsuppressed PTH.